Coleção interativa: Atualizações sobre diabetes e complicações, com foco em NPD, e desafios no diagnóstico/tratamento de pacientes diabéticos
O Health Connect traz mais um episódio de sua série interativa. Explore o caminho deste vídeo interativo e aprenda mais sobre o diabetes e suas complexidades. Conheça a Neuropatia Periférica Diabética, seu diagnóstico e tratamento, enfrentando os desafios atuais.
Fontes:
1. Diabetes Atlas, 10th edition 2021, accessed in Jan 2022 via https://diabetesatlas.org/atlas/tenth-edition/
2. NICE guidelines on diabetes, accessed in Jan 22 via https://www.nice.org.uk/guidance/ng28
3. Rosenberger DC, Blechschmidt V, Timmerman H, et al. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm (Vienna). 2020;127(4):589–624
4. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28 suppl 1:8–14
5. Snyder MJ, Gibbs LM, Lindsay TJ. Treating painful diabetic peripheral neuropathy: an update. Am Fam Physician. 2016;94(3):227–234
6. Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–1522
7. Ang L, Cowdin N, Mizokami-Stout K, et al. Update on the management of diabetic neuropathy. Diabetes Spectr. 2018;31(3):224–233
8. Aizarani C, Amir AA, Benchouk Z, et al. The dos and don’ts of painful diabetic peripheral neuropathy: primary care guidelines for the Middle East and North Africa. World Fam Med J/Middle East J Fam Med. 2017;15(4):4–18
9. Freynhagen R, Baron R, Kawaguchi Y, et al. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgrad Med. 2021;133(1):1–9
10. Tesfaye S et al, Painful diabetic neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2011; 27:629-638
11. Binns-Hall O, Selvarajah D, Sander D, et al. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot. Diabet. Med. 2018;35:887-894.
12. Gylfadottir SS, Weeracharoenkul D, Andersen ST, et al. Painful and non-painful diabetic polyneuropathy: clinical characteristics and diagnostic issues. J Diabetes Investig.2019;10:1148-1157.
13. Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic Neuropathy: A Position Statement bu the American Diabetes Association. Diabetes Care. 2017;40(1):136-154
14. Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular Risk Factors and Diabetic Neuropathy. N Engl J Med. 2005;352:341-50.
15. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12.
16. Ziegler D, Tesfaye S, Spallone V, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Research and Clinical Practice. 2021;109063.
17. Binder A, Baron R. The pharmacological therapy of chronic neuropathic pain. Dtsch Arztebl Int. 2016;113(37):616-625.
18. The best way to treat and control neuropathic pain. https://www.treatingpain.com/news-updates/2019/september/the-best-way-to-treat-and-control-neuropathic-pa/. Published 2019. Accessed April 2022.
19. NICE guidelines on diabetic foot problems: prevention and management, accessed in Jan 22 via https://www.nice.org.uk/guidance/ng19
Direitos autorais da música: Ammil by The tides from YouTube Audio Library http://goo.gl/YmnOAx
Os links para todos os sites de terceiros são oferecidos como um serviço aos nossos visitantes e não implicam endosso, indicação ou recomendação do Health Connect. Os artigos vinculados são fornecidos apenas para fins informativos e não visam implicar uma atribuição pelo autor e/ou editor. O Health Connect se isenta de qualquer responsabilidade pelo conteúdo ou pelos serviços de outros sites. Recomendamos que você analise as políticas e condições de todos os sites que escolher acessar.
NON-2023-5039
NON-2022-15577